A
LIVE

Serial Number

79139640

Owner

AsedaSciences GmbH

Attorney

Jeffery A. Smith

Filing Date

Oct 16, 2013

Add to watchlist:

No watchlists yet
View on USPTO

A Trademark

Serial Number: 79139640 • Registration: 4619191

A is a trademark filed by AsedaSciences GmbH on October 16, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AsedaSciences GmbH (2 trademarks)

Untere Paulistrasse 6a
CH-8834 Schindellegi , CH

Entity Type: 99

AsedaSciences AG (6 trademarks)

Untere Paulistrasse 6a
Schindellegi CH-8834 , CH

Entity Type: 99

Trademark Details

Filing Date

October 16, 2013

Registration Date

October 14, 2014

Published for Opposition

July 29, 2014

Goods & Services

[ In vitro diagnostic preparations for medical use; diagnostic test reagents for medical use; chemical reagents for medical or veterinary use; diagnostic reagents and contrast media agents for medical use; Medical diagnostic reagents; Reagents for medical use ]

Scientific research and development; [ scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing services and protein isolation for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect, and scientific research and development relating thereto; ] Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, [ drug discovery and characterization of compound effect, and protein separation, isolation and characterization; ] scientific research services; scientific testing and analysis in the fields of pharmaceutical research, [ drug discovery and characterization of compound effect, and protein separation, isolation and characterization; ] computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; pharmaceutical research and development; ] Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery [ and characterization of chemical compounds, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research ]; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; [ provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and ] scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]

[ Measuring apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometry analyzers for cellular analysis; scientific, optical, measuring, signaling and checking apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometers for single cell and population based cellular analysis; measuring and testing machines and instruments, namely, protein separation and isolation instruments, flow cytometers, and laboratory liquid handlers and automation for testing and implementing cellular based screening methods; laboratory apparatus and instruments for use in growing, maintaining, evaluating and quality control of cell cultures, automated liquid dispensing, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes; chemistry apparatus and instruments for maintaining, evaluating and quality control of cell cultures, automated liquid dispensing of compound preparations and chemical reagents, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purpose ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 10, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 9, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
Sep 9, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 13, 2025 APRE
PETITION TO DIRECTOR DISMISSED
Aug 11, 2025 PC.D
ASSIGNED TO PETITION STAFF
Aug 11, 2025 APET
TEAS PETITION TO DIRECTOR RECEIVED
Apr 14, 2025 TPDR
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Oct 14, 2023 REM4
INTERNATIONAL REGISTRATION RENEWED
Sep 29, 2023 RNWL
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jun 7, 2023 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Mar 27, 2023 LIMG
PARTIAL INVALIDATION PROCESSED BY THE IB
Sep 20, 2022 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Aug 3, 2022 INPS
INVALIDATION PROCESSED
Aug 3, 2022 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 30, 2022 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Aug 30, 2021 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Aug 30, 2021 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 27, 2021 APRE
TEAS SECTION 71 & 15 RECEIVED
Apr 14, 2021 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 14, 2019 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 11, 2015 FICS
FINAL DISPOSITION PROCESSED
Mar 11, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 14, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 14, 2014 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 31, 2014 ADCH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 29, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jul 29, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Jul 24, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 9, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 9, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 9, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 26, 2014 PREV
ASSIGNED TO LIE
Jun 25, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 9, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 9, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 9, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 9, 2014 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 4, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 4, 2014 REAP
REFUSAL PROCESSED BY IB
Feb 22, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 6, 2014 RFCS
REFUSAL PROCESSED BY MPU
Feb 6, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 6, 2014 RFCR
NON-FINAL ACTION WRITTEN
Feb 5, 2014 CNRT
ASSIGNED TO EXAMINER
Jan 31, 2014 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 17, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 12, 2013 REPR